The prevalence of hepatitis B virus infection in Bangladesh: a systematic review and meta-analysis. (14th February 2022)

• Record Type: Journal Article
• Authors: Banik, Sujan; Datta, Anamika; Ghosh, Antara; Ghosh, Kanak Yadab; Debi, Hoimonti
• Is Part Of: Epidemiology and infection. Volume 150(2022)
• Publication Date: 2022-02-14
• Subjects: Bangladesh -- hepatitis B -- meta-analysis -- prevalence; Communicable diseases -- Periodicals; Epidemiology -- Periodicals; 614.4
• DOI: 10.1017/S0950268822000061
• Languages: English
• ISSNs: 0950-2688

Abstract

Abstract: Despite the availability of an effective vaccine, hepatitis B virus (HBV) infection is one of the major public health problems worldwide, mostly in developing countries. This systematic review and meta-analysis were performed to estimate the pooled prevalence of HBV infection in Bangladesh. We systematically searched various electronic databases to retrieve relevant studies published until April 2021. A total of 15 studies were met the inclusion criteria and included in the meta-analysis. The pooled estimated prevalence of HBV infection in the general population of Bangladesh from 1995 to 2017 was 4.0% [95% confidence interval (CI) 3.0–5.1]. The results of subgroup analysis revealed that the prevalence of hepatitis B was higher in females than males [odds ratio (OR) 1.20, 95% CI 0.48–2.97, P = 0.70], people of age <25 years had a higher prevalence than people of age >25 years (OR 1.25, 95% CI 0.72–2.17, P = 0.42) and married people had a higher prevalence than unmarried/single people (OR 2.16, 95% CI 1.51–3.10, P < 0.0001). The Egger's test statistics ( P = 0.584), Begg and Mazumdar's rank correlation test ( P = 0.054) indicated the absence of publication bias. This study analysis reported a low intermediate prevalence of HBV infection (4%) in Bangladesh, which is currently higher than the global prevalence of HBV infection (3.5%).